Fulcrum Therapeutics
FULC
FULC
101 hedge funds and large institutions have $421M invested in Fulcrum Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
25% more funds holding
Funds holding: 81 → 101 (+20)
14% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 21
9.56% more ownership
Funds ownership: 91.22% → 100.78% (+9.6%)
Holders
101
Holding in Top 10
2
Calls
$4.61M
Puts
$811K
Top Buyers
| 1 | +$10.3M | |
| 2 | +$8.1M | |
| 3 | +$5.56M | |
| 4 |
Goldman Sachs
New York
|
+$4.13M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$3.21M |
Top Sellers
| 1 | -$6.08M | |
| 2 | -$5.63M | |
| 3 | -$3.83M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.67M |
| 5 |
RI
RTW Investments
New York
|
-$2.35M |